Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001649553-25-000159·CVI Investments, Inc.
Schedule 13G ownership disclosure
ReShape Lifesciences Inc.
Common Stock, $0.001 par value per share · CUSIP: 76090R408
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- CVI Investments, Inc.
Shares: 0 · Class: 0%
- Heights Capital Management, Inc.
Shares: 0 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001649553-25-000159
- Form type
- SCHEDULE 13G/A
- Filer
- CVI Investments, Inc.
- CIK
- CIK 1649553
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership